• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

psilocybin

psychedelic brain think thought hallucinogenic psychology
Biotech

FDA holds psychedelic hearing as historic approval looms

Many speakers urged the FDA to ensure that as many patients as possible can access psychedelics, while a few highlighted safety concerns.
Darren Incorvaia Sep 14, 2026 6:00pm
mushrooms psychedelic drugs psychedelics

Psilocybin proves promising in neuropathic pain mouse study

Sep 3, 2026 2:00pm
A collection of the fungus among us

Compass, Usona and Transcend score priority vouchers amid psychedelic push

Apr 24, 2026 3:51pm
magic mushroom

Compass guides psychedelic to 2nd pivotal depression win

Feb 17, 2026 8:39am
change direction new plan alter arrows move reprioritize
Favicon Fierce Pharma

Cybin alters state to become Helus Pharma for Nasdaq trip

Dec 19, 2025 10:30am
colorful brain art model

Reunion's psychedelic reduces postpartum depression in ph. 2

Aug 18, 2025 7:52am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings